Image: Empatica / PR Newswire — WellPD, Empatica's wearable device and companion app (official product image).
TL;DR — Empatica WellPD Parkinson's wearable explained in one line: a $219 FDA-cleared wrist device and app that tracks tremor, dyskinesia and slowness of movement at home, turning them into daily summaries for patients and their doctors — but it is not on sale in India yet.
📌 KEY HIGHLIGHTS
- What launched: Empatica's WellPD, announced on 28 October 2026 — an FDA-cleared and CE-marked wearable device and companion app for monitoring Parkinson's symptoms at home.
- What it tracks: tremor, dyskinesia (involuntary movements) and bradykinesia (slowness of movement), plus sleep and physical activity, with daily summaries and medication logs.
- The price: a $219 starter pack (device, stretchable band and USB charger) plus an app subscription from $14.90 a month; shipping begins on 23 November 2026.
- Where you can buy it: the US, Canada, the UK, Australia, New Zealand and 14 European countries — India is not on the list, and it is not sold in seven US states.
- The science behind it: PKG Health algorithms, acquired by Empatica in 2025, backed by more than 70 peer-reviewed publications and used in more than 150 hospitals and clinical sites worldwide.
Empatica WellPD Parkinson's wearable explained: what launched
Empatica, the medical wearables company best known for its epilepsy-monitoring devices, announced WellPD on 28 October 2026. It is a wrist-worn device paired with a companion app, designed so people with Parkinson's can monitor their symptoms at home between clinic appointments — the part of the condition doctors find hardest to see, because symptoms can change from one hour to the next as medication takes effect or wears off.
The regulatory detail matters here, so let us get it exactly right. WellPD is FDA-cleared through the 510(k) pathway (clearance number K260374) and CE-marked in Europe. That means regulators found it substantially equivalent to a legally marketed device — it is cleared, not "FDA approved", which is a different and stricter process. The distinction is worth knowing before anyone spends $219 on it.
The device itself is deliberately unremarkable to wear: about 11 grams — roughly the weight of a pencil — on a stretchable, waterproof fabric band, with a claimed two weeks of battery life per charge. There is no screen to fuss with. It records movement and other body signals continuously, and clinically validated algorithms turn those signals into measurements of motor symptoms, sleep and activity. The companion app then compresses all of that into daily summaries, so neither the patient nor the doctor has to rely on memory or a handwritten diary.
What WellPD tracks — and how the daily summaries work
Parkinson's motor symptoms are the core of what WellPD measures: tremor, dyskinesia (the involuntary movements that can appear as a side effect of long-term levodopa treatment) and bradykinesia (slowness of movement). Alongside those, it tracks sleep and physical activity, and users can log their medications and treatments in the app.
The point of combining all of that is pattern-spotting. A daily summary can show, for example, that tremor worsens in the late afternoon as a dose wears off, or that a bad night's sleep is followed by a slower morning. "Digital wearables can transform a complex mix of symptoms into clear, accurate, and actionable data," said Dr Alessandro Di Rocco, neurologist and system director for Parkinson's and Movement Disorders at Northwell Health in New York, in Empatica's announcement. For family members and caregivers, the same summaries offer another way to understand what their loved one is going through; for clinicians, they add context about symptoms between visits.
The technology behind it is not new — it is newly packaged for home use. WellPD builds on the Parkinson's monitoring technology of PKG Health, which Empatica acquired in 2025. Empatica says the PKG algorithms are supported by more than 70 peer-reviewed publications and are already used in more than 150 hospitals and clinical sites worldwide, including in pharmaceutical research on disease progression and treatment response. WellPD is, in effect, the consumer version of a system doctors already use.
| Detail | WellPD |
|---|---|
| What it is | Wrist-worn Parkinson's monitoring device + companion app |
| What it tracks | Tremor, dyskinesia, bradykinesia, sleep, physical activity |
| Regulatory status | FDA-cleared (510(k) K260374), CE-marked — cleared, not approved |
| Weight and battery | About 11 g; up to 14 days per charge; stretchable waterproof band |
| Starter pack price | $219 (device, stretchable band, USB cable charger) |
| App subscription | From $14.90 a month (required for the app and summaries) |
| Announced / shipping | Announced 28 October 2026; shipping begins 23 November 2026 |
| Available to order | US, Canada, UK, Australia, New Zealand + 14 European countries; NOT India |
Illustrative image: a smartwatch worn on the wrist — WellPD is a similar wrist-worn device, but this is NOT the WellPD. Image: Wikimedia Commons / jcutrer.
Why it matters for India readers
First, the honest limit: WellPD is not on sale in India, and Empatica has announced no India launch date or price. An Indian reader cannot order one today, and converting $219 into rupees would not be an India price — so this post does not pretend otherwise.
What does matter for India is the direction of travel. Health wearables are moving from step-counting into clinical monitoring, and India is part of that shift: Garmin's ECG app reached India on 3 November, Samsung's Galaxy Ring gained an upgraded sleep-apnoea feature the same week, and clinics here already use wearable data in Parkinson's care. WellPD is the next step along the same road — a device whose entire job is producing data a doctor can act on, rather than a fitness score. If Empatica expands to India later, the product to watch is this one, not another step counter.
There is also a practical audience right now: Indian families with relatives in the US, UK, Canada or Australia, where WellPD is already on sale. For them, the relevant question is not the exchange rate but whether a home-monitoring device helps the next clinic visit — and the answer, on the evidence Empatica cites, is that it gives the doctor a daily record instead of a remembered guess. Parkinson's is, in Dr Di Rocco's words, "one of the most common and treatable neurological disorders, yet its complexity often leads to suboptimal care" — and the complexity he is describing is exactly what a daily record is meant to cut through.
Should you care?
✅ Verdict: yes, if Parkinson's affects your family — but as a monitoring tool, not a treatment. WellPD does not diagnose or treat anything; it measures symptoms and hands the record to a doctor. For a family already managing Parkinson's, that record is genuinely useful. For everyone else, this is a signpost: clinical wearables are leaving the hospital and arriving at home, and India will be part of that story soon enough.
Price, availability and alternatives
The WellPD Starter Pack costs $219 and includes the device, a stretchable band and a USB cable charger. The companion app needs a subscription, starting at $14.90 a month — so the real cost is the device plus a recurring fee, and buyers should factor that in rather than treating $219 as the whole price. Orders are open now, with shipping beginning on 23 November 2026.
Availability is wider than the US alone but still limited: the United States, Canada, the United Kingdom, Australia, New Zealand, and Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Spain and Sweden. It is not available for purchase in seven US states — Alabama, Iowa, Kentucky, Michigan, Montana, North Dakota and Utah — and a compatible smartphone is required. India is not on the list.
Alternatives depend on what you actually need. If the goal is heart-rhythm screening on the wrist in India, our Garmin ECG app India launch explainer covers a free software feature for compatible watches. If the goal is general health tracking with coaching, our Google Fitbit Edge review and price explainer covers a $179.99 tracker with GPS and a seven-day battery. Neither does what WellPD does: neither tracks Parkinson's motor symptoms, and neither produces the daily summaries a neurologist would read. The closest alternative is the clinical version of the same technology — the PKG system already used in hospitals — which is not something a family buys for home use. This post will be updated in place if Empatica announces India availability or pricing.
FAQs
What is Empatica WellPD?
WellPD is an FDA-cleared, CE-marked wrist-worn device and companion app from Empatica that monitors Parkinson's motor symptoms — tremor, dyskinesia and bradykinesia — plus sleep and activity at home, turning the measurements into daily summaries for patients, families and their care teams.
How much does WellPD cost?
The WellPD Starter Pack costs $219 and includes the device, a stretchable band and a USB cable charger. The companion app requires a subscription starting at $14.90 a month, so the total cost is the device price plus the ongoing subscription.
Is WellPD available in India?
No. WellPD is available to order in the US, Canada, the UK, Australia, New Zealand and 14 European countries, with shipping from 23 November 2026. Empatica has announced no India launch date or price, so do not treat the $219 figure as an Indian price.
Is WellPD FDA approved?
No — it is FDA-cleared, which is different. WellPD was cleared through the FDA's 510(k) pathway (clearance K260374), meaning regulators found it substantially equivalent to a legally marketed device. It is also CE-marked in Europe. Clearance is not the same as FDA approval, and WellPD is a monitoring device, not a treatment.
Takeaway: WellPD takes Parkinson's monitoring out of the clinic and onto the wrist — a $219 FDA-cleared device that turns a day of tremors, sleep and medication into a summary a doctor can actually use. India cannot buy it yet, but the idea behind it — wearables as medical instruments, not just fitness gadgets — is already arriving here.
Follow World Tech on TechByCountry for tomorrow's update.
📸 Get tech in the last 24 hours on Instagram — follow @_techinlast24hrs for daily posts (9 AM–9 PM) and reels at 12:30 PM & 8:30 PM.
Read more on TechByCountry: Garmin ECG app India launch, Google Fitbit Edge review and price.
Sources
- PR Newswire — Empatica launches WellPD, an FDA-cleared Parkinson's monitoring device for home use (28 October 2026)
- Parkinson's News Today — Wearable device to track Parkinson's launches in US, elsewhere (4 November 2026)
- Empatica — Introducing WellPD: Parkinson's monitoring for everyday life (30 October 2026)
- Parkinson's Europe — Medical tech company Empatica launches new WellPD wearable (2 November 2026)
- Medical Device Network — Empatica introduces WellPD Parkinson's wearable device (29 October 2026)
Comments
Post a Comment